A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Blood-brain barrier (BBB) models are often used to investigate BBB function and screen brain-penetrating therapeutics, but it has been difficult to construct a human model that possesses an optimal BBB phenotype and is readily scalable. To address this challenge, we developed a human in vitro BBB model comprising brain microvascular endothelial cells (BMECs), pericytes, astrocytes and neurons derived from renewable cell sources. First, retinoic acid (RA) was used to substantially enhance BBB phenotypes in human pluripotent stem cell (hPSC)-derived BMECs, particularly through adherens junction, tight junction, and multidrug resistance protein regulation. RA-treated hPSC-derived BMECs were subsequently co-cultured with primary human brain pericytes and human astrocytes and neurons derived from human neural progenitor cells (NPCs) to yield a fully human BBB model that possessed significant tightness as measured by transendothelial electrical resistance (~5,000 Ωxcm(2)). Overall, this scalable human BBB model may enable a wide range of neuroscience studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Other studies have shown mixed results regarding the effect of pericytes or other supporting cell types on TEER of dhBMEC monolayers [20, 33, 36, 41, 52–54].”
From Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D (2019) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line
Weksler, B. B., Subileau, E. A., Perrière, N., Charneau, P., Holloway, K., Leveque, M., Tricoire‐Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,330
Central nervous system pericytes in health and disease
Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962
A Membrane Receptor for Retinol Binding Protein Mediates Cellular Uptake of Vitamin A
Kawaguchi, R., Yu, J., Honda, J., Hu, J., Whitelegge, J., Ping, P., Wiita, P., Bok, D., & Sun, H. (2007) · Science · doi:10.1126/science.1136244 · Cited by 836
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800
Self-citationElectrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
A cell culture model of the blood-brain barrier.
Rubin, L. L., Hall, D. E., Porter, S., Barbu, K., Cannon, C., Horner, H. C., Janatpour, M., Liaw, C. W., Manning, K., & Morales, J. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.6.1725 · Cited by 765
Cited by
Items 301–400 of 547
Cui, A., Patel, R., Bosco, P., Akcan, U., Richters, E., Delgado, P. B., Agalliu, D., & Sproul, A. A. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323397 · Cited by 14
Hudecz, D., McCloskey, M. C., Vergo, S. B., Christensen, S., McGrath, J. L., & Nielsen, M. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065624 · Cited by 13
“This protocol is a modified version of the first protocols of the Shusta Lab [7,8]; however, it was mainly based on some of the further optimised protocols [9,11,13].”
BackgroundMethodA human pluripotent stem cell-derived in vitro model of the blood–brain barrier in cerebral malaria
Gopinadhan, A., Hughes, J. M., Conroy, A. L., John, C. C., Canfield, S. G., & Datta, D. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00541-9 · Cited by 13
“BMECs were differentiated following the seeding of hiPSCs and were singularized with Accutase (Life Technologies, USA), as previously described [38, 39]. hiPSCs were plated at a density of 1 × 10 5 cells/cm 2 on Matrigel (Corning Life Sciences, USA) coated 6-well plates (Thermo Fisher Scientific,…”
MethodWoehrling, E. K., Parri, H. R., Tse, E. H. Y., Hill, E. J., Maidment, I., Fox, C., & Coleman, M. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118786 · Cited by 13
Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood–brain barrier model
Delsing, L., Kallur, T., Zetterberg, H., Hicks, R., & Synnergren, J. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0147-4 · Cited by 13
Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells
Endres, L. M., Schubert‐Unkmeir, A., & Kim, B. J. (2020) · Journal of Visualized Experiments · doi:10.3791/61400 · Cited by 13
Raut, S., Patel, R., Pervaiz, I., & Al-Ahmad, A. J. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.01.007 · Cited by 13
Self-citationOnyema, H. N., Berger, M., Musyanovych, A., Bantz, C., Maskos, M., & Freese, C. (2021) · Biointerphases · doi:10.1116/6.0000889 · Cited by 13
Zlotnik, D., Rabinski, T., Halfon, A., Anzi, S., Plaschkes, I., Benyamini, H., Nevo, Y., Gershoni, O. Y., Rosental, B., Hershkovitz, E., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.07.010 · Cited by 12
“Since iBMEC differentiation includes the supplementation of RA (Lippmann et al., 2014), we hypothesized that POR mediates TJ formation through the regulation of RA metabolism.”
BackgroundMethodInfluentialHaferkamp, U., Hartmann, C., Abid, C. L., Brachner, A., Höchner, A., Gerhartl, A., Harwardt, B., Leckzik, S., Leu, J., Metzger, M., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00471-y · Cited by 12
“At day 6, medium was changed to EC medium containing 99.5% human endothelial serum-free medium and 0.5% B-27 (all Thermo Fisher Scientific) supplemented with 20 ng/ml hbFGF and 10 µM retinoic acid [26].”
BackgroundMethodInfluentialEl-Taibany, A. A., Heydarian, P., Porada, D. A., Seeds, M. C., & Atala, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1595276 · Cited by 12
Li, Y., Terstappen, G. C., & Zhang, W. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_363 · Cited by 12
Pervaiz, I., Mehta, Y., Sherill, K., Patel, D., & Al-Ahmad, A. J. (2023) · Microvascular Research · doi:10.1016/j.mvr.2023.104585 · Cited by 12
Self-citationDanz, K., Fleddermann, J., Koch, M., Fecioru, E., Maahs, L., Kinsinger, N., Krämer, J., Kraegeloh, A., & Wagner, S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050571 · Cited by 12
“These cell models show a good correlation in terms of physico-chemical properties, protein expression and transport behaviour with the in vivo situation, as has been shown by a number of different research groups [19–21].”
ResultStem cells and vascular dementia: from basic science to the clinic
Jiang, W., Gong, L., Liu, F., & Mu, J. (2020) · Cell and Tissue Banking · doi:10.1007/s10561-020-09829-0 · Cited by 12
Georgieva, J. V., Katt, M. E., Zhou, Y., Umlauf, B. J., Wenthur, C. J., & Shusta, E. V. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081706 · Cited by 12
“4 μm Transwell filters (Figure A2), as described previously [27,28].”
MethodSelf-citationModeling Brain Vasculature Immune Interactions In Vitro
Lyck, R., Nishihara, H., Aydin, S., Soldati, S. G., & Engelhardt, B. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041185 · Cited by 11
Chaves, J. C. S., Wasielewska, J. M., Cuní‐López, C., Rantanen, L. M., Lee, S., Koıstınaho, J., White, A. R., & Oikari, L. E. (2023) · Neurotherapeutics · doi:10.1016/j.neurot.2023.10.009 · Cited by 11
“In addition, all lines exhibited a normal karyotype and tested negative for mycoplasma (Table S1). hiPSCs were induced to differentiate into iBECs as previously described [50,51], and optimised by us [39].”
MethodReproducibility in biological models of the blood-brain barrier
Hudecz, D., Rocks, L., Fitzpatrick, L. W., Herda, L. M., & Dawson, K. A. (2014) · European Journal of Nanomedicine · doi:10.1515/ejnm-2014-0021 · Cited by 11
Endothelial specialization and angiocrine factors are critical for vascularized organoid models
Fitzsimmons, R. L., & Hudson, J. E. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116410 · Cited by 10
Personalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs‐On‐Chips
Buck, F., Bugter, J., Yorukoglu, G., Dastjerd, M. K., & Winkler, T. E. (2026) · Advanced Biology · doi:10.1002/adbi.202500536 · Cited by 10
“The first protocols for BBB iPSC-EC differentiation were published a decade ago based on neural-like co-differentiation and adhesion-based cell selection [ 72, 73 ], with variations and improvements to follow.”
Impact of astrocyte and lymphocyte interactions on the blood-brain barrier in multiple sclerosis
Yan, X.-B., Zhao, Y.-F., Yang, Y., Wang, N., He, B.-Z., & Qiu, X. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2018.12.006 · Cited by 10
Vollmuth, N., Sin, J., & Kim, B. J. (2024) · mBio · doi:10.1128/mbio.02862-23 · Cited by 10
“Further improvements have increased endothelial identity through the addition of small molecules or erythroblast transformation-specific factors (60, 86–89).”
BackgroundAll‐trans retinoic acid improves pancreatic cell proliferation on induced type 1 diabetic rats
Ramírez‐Moreno, A., Escorza, M. A. Q., García-Garza, R., Keita, H., Valenzuela, A. M., Marszalek, J. E., Ibrahim, S.-N. A., & Delgadillo‐Guzmán, D. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12523 · Cited by 10
Nunes, A. C. D. F., & Piuvezam, G. (2019) · Medicine · doi:10.1097/md.0000000000016043 · Cited by 10
“It is worth mentioning that in an in vitro model using pluripotent cerebral microvascular endothelial cells derived from stem cells, retinoic acid (RA) reinforced the properties of the blood–brain barrier (BBB),([27]) suggesting that RA could block cell traffic through the BBB.”
BackgroundMatsuo, K., Nagamatsu, J., Nagata, K., Umeda, R., Shiota, T., Morimoto, S., Suzuki, N., Aoki, M., Okano, H., Nakamori, M., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1357204 · Cited by 9
Jezdić, K., Đoković, J. B., Jančić, I., Milić, J., Bufan, B., Marković, B. D., Ivanović, J., Stanković, T., Cekic, N. D., Papadimitriou, V., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030354 · Cited by 9
“Values around 4000 Ω *cm 2 reported for other in vitro BBB models, such as co-cultures of primary human brain pericytes, human astrocytes, and neurons derived from human neural progenitor cells, were in agreement with the values obtained in our study [18,31,32].”
Knipp, G. T., & Lubin, K. E. (2021) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2021.09.00340 · Cited by 9
Jezierski, A., Huang, J., Haqqani, A. S., Haukenfrers, J., Liu, Z., Baumann, E., Sodja, C., Charlebois, C., Delaney, C. E., Star, A. T., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00437-0 · Cited by 9
“Compared to previously described mouse ESC-derived endothelial cells protocols [23, 24, 70–74], we adapted the differentiation strategy to generate brain endothelial-like cells with barrier properties ranging between 350–400 Ω cm2 in the presence of ACM, RA and hydrocortisone, collectively known to provide instructive…”
BackgroundMethodPervaiz, I., Mehta, Y., & Al-Ahmad, A. J. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.31523 · Cited by 9
“iBMECs were differentiated following the original differentiation protocol by Lippmann and colleagues (Lippmann et al. 2014; Lippmann et al. 2012) with slight modifications (Neal et al. 2019).”
Self-citationMathew, S., Oerter, S., Reitenbach, E., Gätzner, S., Höchner, A., Jahnke, H., Piontek, J., Neuhaus, W., Brachner, A., Metzger, M., et al. (2025) · Advanced Biology · doi:10.1002/adbi.202400442 · Cited by 9
A simple cell transport device keeps culture alive and functional during shipping
Miller, P. G., Wang, Y. I., Swan, G., & Shuler, M. L. (2017) · Biotechnology Progress · doi:10.1002/btpr.2512 · Cited by 9
“,(22) was maintained and differentiated into brain microvascular endothelial cells (BMECs) as previously described.(23,24) Briefly, the iPSCs were plated on Matrigel (Corning Inc.”
MethodDanz, K., Höcherl, T., Wien, S., Wien, L., von Briesen, H., & Wagner, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040737 · Cited by 9
“The maximum TEER values achieved in this study for the previously described cultivation protocols of 450 ± 105 Ω cm2 (pBCECs) and 640 ± 140 Ω cm2 (hiPS-BCECs) are notably lower than those reported by other groups [14,16,19,23,30].”
ResultSerum retinol levels are associated with brain volume loss in patients with multiple sclerosis
Yokote, H., Kamata, T., Toru, S., Sanjo, N., & Yokota, T. (2017) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217317729688 · Cited by 9
INPP5D/SHIP1 regulates inflammasome activation in human microglia
Chou, V., Fancher, S. B., Pearse, R. V., Lee, H., Lam, M., Seyfried, N. T., Bennett, D. A., De Jager, P. L., Menon, V., & Young-Pearse, T. L. (2023) · doi:10.1101/2023.02.25.530025 · Cited by 8
Yan, L., Dwiggins, C. W., Gupta, U., & Stroka, K. M. (2023) · Bioengineering · doi:10.3390/bioengineering10091080 · Cited by 8
“Simple models of the BBB have been developed by using cell culture systems such as the side-by-side diffusion chambers and Transwell culture wells, either of which can promote the coculture of BMECs and other BBB adaptors cells (e.g., astrocytes and/or pericytes) [9–12].”
Progresses in the establishment, evaluation, and application of in vitro blood–brain barrier models
Yin, P., & Wang, X. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.25359 · Cited by 8
“At pre-sent, human pluripotent stem cells, human embryonic stem cells, and induced pluripotent stem cells exhibit good performance in modeling BBB (Li et al., 2022; Lippmann et al., 2014 ; Musafargani et al., 2020).”
BackgroundHathcock, S. F., Knight, H. E., Tong, E. G., Meyer, A. E., Mauser, H. D., Vollmuth, N., & Kim, B. J. (2024) · Frontiers in Drug Delivery · doi:10.3389/fddev.2024.1433453 · Cited by 8
Kurosawa, T., Tega, Y., Sako, D., Mochizuki, T., Yamaguchi, T., Kawabata, K., Inoue, K., Ito, N., Kusuhara, H., & Deguchi, Y. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.06.007 · Cited by 8
Long, R. K. M., Piatti, L., Korbmacher, F., & Bernabeu, M. (2021) · Molecular Microbiology · doi:10.1111/mmi.14852 · Cited by 8
“Further increases in barrier function have been achieved with differentiation under retinoic acid in a static BBB Transwell model with pericytes (1,500 Ω · cm2; Lippmann et al., 2014) or in a model with astrocytes that incorporates flow (3000 Ω · cm2; Wang et al., 2017).”
BackgroundThuringer, D., Solary, É., & Garrido, C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00246 · Cited by 8
Weber, V., Bork, K., Horstkorte, R., & Olzscha, H. (2020) · Journal of Visualized Experiments · doi:10.3791/60692 · Cited by 8
Marzano, M., Chen, X., Russell, T. A., Medina, A., Wang, Z., Hua, T., Zeng, C., Wang, X. S., Sang, Q. A., Tang, H., et al. (2022) · Frontiers in Chemical Engineering · doi:10.3389/fceng.2022.927188 · Cited by 8
“Our study modified the blood vessel organoid derivation and then used retinoic acid to enhance the BBB properties of the derived endothelial cells (Lippmann et al., 2014; Wimmer et al., 2019; Nguyen et al., 2021).”
BackgroundMethodNguyen, E. H., Dombroe, M. J., Fisk, D. L., Daly, W. T., Sorenson, C. M., Murphy, W. L., & Sheibani, N. (2019) · Applied In Vitro Toxicology · doi:10.1089/aivt.2018.0025 · Cited by 8
Using miniature brain implants in rodents for novel drug discovery
Waldau, B. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1577816 · Cited by 8
“Several transwell systems have been described either using endothelial cell monoculture [16–19], coculture with pericytes [17], astrocytes [20–22], differentiated neural progenitor cells [23], or triple cultures [21].”
MethodKrieg, K., Materna‐Reichelt, S., Naber, T., Rachad, F.-Z., Kauven, P., Weller, A., Haferkamp, U., Wittich, A., Zaliani, A., Woo, M. S., et al. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101236 · Cited by 7
In vitro models of microbiota-gut-brain axis communication at the blood-brain-barrier interface
Davies, M. R., Cross, C., Aburto, M. R., Cryan, J. F., & Wardill, H. R. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261419964 · Cited by 7
“81 82–86 In fact, a monolayer of iPSC-derived BMECs demonstrates a significant and strong correlation to in vivo human pharmacokinetic data of small drug permeability.”
Selvakumaran, J., Ursu, S., Bowerman, M., Lu‐Nguyen, N., Wood, M. J. A., Malerba, A., & Yáñez‐Muñoz, R. J. (2023) · Biomedicines · doi:10.3390/biomedicines11102700 · Cited by 7
“…house using retroviral vectors) and clones 19-9-7T and AD3-CL1 (reprogrammed us-ing episomal vectors) were maintained on Matrigel (Corning, Flintshire, UK) in mTeSR1 medium (STEMCELL Technologies, Cambridge, UK). iPSCs were differentiated to brain BMECs using the protocol by Lippmann et al. [25].”
MethodDifferentiation Protocol-Dependent Variability in hiPSC-Derived Endothelial Progenitor Functionality
Stern, B., Meng, S., Larsen, B., Brock, A., & Zoldan, J. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00404-1 · Cited by 7
Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier
Schulte‐Mecklenbeck, A., Bhatia, U., Schneider‐Hohendorf, T., Schwab, N., Wiendl, H., & Groß, C. C. (2017) · Journal of Visualized Experiments · doi:10.3791/55390 · Cited by 7
Human Blood-Brain-Barrier In Vitro Models: Overview and Applications
Cader, M. Z. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_562 · Cited by 7
Charlebois, C., Huang, J., Sodja, C., Ribecco‐Lutkiewicz, M., Baumann, E., Stanimirovic, D. B., & Jezierski, A. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_393 · Cited by 7
Advances in brain barriers and brain fluid research and news from Fluids and Barriers of the CNS
Drewes, L. R., Jones, H. C., & Keep, R. F. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-016-0026-1 · Cited by 7
“Pericytes are now also being integrated into in vitro BBB models with some co-cultures showing permeabilities close to those in vivo [6].”
BackgroundForeman, K. L., Shusta, E. V., & Palecek, S. P. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3287-1_10 · Cited by 6
Self-citationBell, K. T., Hughes, J. M., Borman, W. A., Stoffel, R. D., & Canfield, S. G. (2025) · Alcohol · doi:10.1016/j.alcohol.2025.03.005 · Cited by 6
Kumar, S., Malviya, R., Sridhar, S. B., Wadhwa, T., & Shareef, J. (2026) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2026.110695 · Cited by 6
Schofield, C. L., Rodrigo‐Navarro, A., Dalby, M. J., Agtmael, T. V., & Salmerón‐Sánchez, M. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202000068 · Cited by 6
In Vitro Models of CNS Barriers
Abbott, N. J., Yusof, S. R., Reichel, A., Dolman, D. E. M., & Preston, J. E. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_8 · Cited by 6
Group B Streptococcus transcriptome when interacting with brain endothelial cells
Vollmuth, N., Bridgers, B., Armstrong, M. L., Wood, J. F., Gildea, A., Espinal, E. R., Hooven, T. A., Barbieri, G., Westermann, A. J., Sauerwein, T., et al. (2024) · Journal of Bacteriology · doi:10.1128/jb.00087-24 · Cited by 6
“…generated from induced pluripotent stem cells (iBECs), in contrast, display the many expected phenotypes of a human BBB, including proper establishment of tight junctions between cells, physiological TEER values, and increased response to other cell types within the BBB microenvironment (10–13).”
BackgroundKadry, H., & Cucullo, L. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3429-5_7 · Cited by 6
Ruano-Salguero, J. S., & Lee, K. H. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00662 · Cited by 6
An in vitro model for vitamin A transport across the human blood–brain barrier
Est, C. B., & Murphy, R. M. (2023) · eLife · doi:10.7554/elife.87863 · Cited by 5
“Of relevance to this work, iPSCs have been differentiated into brain microvascular endothelial-like cells (BMECs) ( Lippmann et al., 2014 ; Lippmann et al., 2012 ).”
ResultAdvances and opportunities for hiPSC-derived models of the blood-brain barrier
Seo, H. S., Motallebnejad, P., & Azarin, S. M. (2020) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2020.05.006 · Cited by 5
Self-citationAhn, Y., Patil, C. D., Nozohouri, E., Zoubi, S., Patel, D., & Bickel, U. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16010135 · Cited by 5
“Using iPSC-Derived Human BMECs 2.7.1. iPSC Differentiation Procedure iPSC differentiation into human BMECs was performed using an established protocol [28].”
BackgroundMethodInfluentialHydrodynamic Focusing-Enabled Blood Vessel Fabrication for in Vitro Modeling of Neural Surrogates
DiVito, K. A., Luo, J., Rogers, K. E., Sundaram, S., Roberts, S., Dahal, B., van Hoek, M. L., Kehn‐Hall, K., Delehanty, J. B., & Adams, A. A. (2021) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-021-00629-9 · Cited by 5
Pervaiz, I., & Al-Ahmad, A. J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2289-6_3 · Cited by 5
Self-citationLocked Out: Phoenixin-14 Does Not Cross a Stem-Cell-Derived Blood–Brain Barrier Model
Schalla, M. A., Oerter, S., Cubukova, A., Metzger, M., Appelt‐Menzel, A., & Stengel, A. (2023) · Brain Sciences · doi:10.3390/brainsci13070980 · Cited by 5
“The hiPSC-derived brain capillary-like endothelial cell (hiPS-BCEC) BBB model was built as previously described [29,30,32].”
MethodMondkar, P. P., Seo, H. S., Lodge, T. P., & Azarin, S. M. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00608 · Cited by 5
Self-citationBlending Established and New Perspectives on Choroid Plexus-CSF Dynamics
Johanson, C. E., & Keep, R. F. (2020) · Physiology in health and disease · doi:10.1007/978-1-0716-0536-3_2 · Cited by 5
3.15 Cell Culture Systems for Studying Biomaterial Interactions With Biological Barriers ☆
Hermanns, M. I., Freese, C., Anspach, L., Grützner, V., Pohl, C., Unger, R. E., & Kirkpatrick, C. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.09821-0 · Cited by 5
Kopec, B. M., Ulapane, K. R., Moral, M. E. G., & Siahaan, T. J. (2018) · Neuromethods · doi:10.1007/978-1-4939-8946-1_2 · Cited by 5
Chapleau, A., Perrier, S., Durcan, T. M., & Bernard, G. (2025) · npj Genomic Medicine · doi:10.1038/s41525-025-00533-0 · Cited by 4
Hartmann, C., Haferkamp, U., Appelt‐Menzel, A., Barenberg, J., Brachner, A., Ehrhard, T., Feldhaus, J. S., Gerhartl, A., Hollemann, T., Kulka, L. A. M., et al. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00753-7 · Cited by 4
“Importantly, these TEER values are consistent with those reported in previous hiPSC-derived BBB models [27, 44, 45] and are comparable to in vivo measurements, ranging between 500 and 6000 Ω*cm 2 .”
Yamaguchi, T., Sako, D., Kurosawa, T., Nishijima, M., Miyano, A., Kubo, Y., Ohtsuki, S., Kawabata, K., & Deguchi, Y. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.09.004 · Cited by 4
Heo, C., Kwak, H.-J., Hoang, L. N., Woo, R., & Lee, S.-J. (2023) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2023.110029 · Cited by 4
“So far, NSCs for in vitro BBB modeling have mostly been based on human umbilical cord blood (Cecchelli et al., 2014), human iPSC lines (Lippmann et al., 2014; Appelt-Menzel et al., 2017), and rat embryonic stem cells (Molino et al., Fig.”
Akter, K. A., Sharma, S., Jadhav, S. R., Zhang, Y., & Abbruscato, T. J. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00719-9 · Cited by 4
“To recreate in vivo TEER values in in vitro BBB models, a co-cultured setup composed of brain endothelial cells with other brain cells, such as astrocytes, subjected to different physiological stress [45], or treated with different chemicals has been introduced [46].”
Development of Neural Stem Cell-Based Therapies for Parkinson’s Disease
Lee, J., Tsai, C., & Chou, C.-H. (2018) · InTech eBooks · doi:10.5772/intechopen.73870 · Cited by 4
“The BBB is characterized by an organ-specific high transendothelial electrical resistance (TEER, up to 5000 ohm cm(2); in contrast with placental TEER 20–50 ohm cm(2)) [32, 33].”
BackgroundSato, K. (2018) · Folia Pharmacologica Japonica · doi:10.1254/fpj.152.287 · Cited by 4
Blood‐brain barrier models derived from individual patients: a new frontier
Xiang, J., Andjelkovic, A. V., Wang, M. M., & Keep, R. F. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13961 · Cited by 4
Canfield, S. G., Stebbins, M. J., Faubion, M. G., Gastfriend, B. D., Palecek, S. P., & Shusta, E. V. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0151-8 · Cited by 4
Self-citationNano-scale Architecture of Blood-Brain Barrier Tight-JunctionsPreprint
Sasson, E., Anzi, S., Bell, B., Yakovian, O., Zorsky, M., Deutsch, U., Engelhardt, B., Sherman, E., Vatine, G. D., Dzikowski, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.12.456150 · Cited by 4
Mauser, H. D., Caroza, J., Homez, S. N., Arnett, A. S., Cutts, W. D., Lam, D. W., Thornton, J. A., Adams, W., & Kim, B. J. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70093 · Cited by 3
“Two days after purification, iBECs reach maximum transendothelial electrical resistance values around 3000 Ω ×cm 2 [30, 31] and are ready for experiments.”
In vitro human brain barrier models for studying thyroid hormone transport
Heikamp, K., Hamers, T., & Hessel, E. V. S. (2025) · Critical Reviews in Toxicology · doi:10.1080/10408444.2025.2540446 · Cited by 3
“Treatment of cells with retinoic acid enhances TEER (Lippmann et al. 2014).”
Identification of Variable Lymphocyte Receptors That Target the Human Blood–Brain Barrier
Katt, M. E., Waters, E. A., Gastfriend, B. D., Herrin, B. R., Cooper, M. D., & Shusta, E. V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091179 · Cited by 3
“…3.6% paraformaldehyde for experiments utilizing fixed cells, as further described. iPSC-derived BMEC-like cells possess key properties as previously reported [24,26] (Supplemental Figure S1). hCMEC/D3 (Millipore Sigma, Burlington, MA, USA) cells were cultured according to manufacturer’s protocols.”
InfluentialSelf-citationSocioeconomic and energy transition disparities in air pollution-related mortality across Europe
Chen, Z., Achebak, H., Huang, W., Paniello-Castillo, B., Petetin, H., Turrubiates, R. F. M., García‐Pando, C. P., & Ballester, J. (2026) · Nature Medicine · doi:10.1038/s41591-026-04293-x · Cited by 3
Aoki, H., Yamashita, M., Hashita, T., Iwao, T., Aoyama, M., & Matsunaga, T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122697 · Cited by 3
“BMECs are often cultured on plates coated with fibronectin and collagen type IV [5,6,15], which are abundant in the BBB.”
BackgroundComparison of Extracellular Vesicles from Induced Pluripotent Stem Cell-Derived Brain Cells
Xavier, G., Santos, A. N., Hartmann, C., Santoro, M. L., Flegel, N., Reinsch, J., Majer, A., Ehrhardt, T., Pfeifer, J., Simm, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073575 · Cited by 3
“BCECs were generated based on previously published protocols [49,50] with minor modifications as recently described [14].”
MethodNatural Compounds That Target Glioma Stem Cells
Yaroshenko, M., Christoff, M., Ścibiorski, M., Surowiec, K., Jakubowicz-Gil, J., & Sumorek-Wiadro, J. (2025) · NeuroSci · doi:10.3390/neurosci6020052 · Cited by 3
“All-trans retinoic acid (ATRA) <50% [96] + [97] Well tolerated; mild side effects (fatigue, headache, fever, dermatitis, weakness, and gastrointestinal symptoms) have been reported [98].”
Эндотелиальные прогениторные клетки в развитии и восстановлении церебрального Эндотелия (обзор)
Салмина, А. Б., Моргун, А. В., Kuvacheva, N. V., Пожиленкова, Е. А., Solonchuk, Y. R., Лопатина, О. Л., Комлева, Ю. К., & Таранушенко, Т. Е. (2014) · Cited by 3
Rapid retinoic acid-induced trophoblast cell model from human induced pluripotent stem cells
Lemke, K. A., Sarkar, C. A., & Azarin, S. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-68952-0 · Cited by 3
Self-citationLavekar, S. S., Hughes, J. M., Gomes, C., Huang, K.-C., Harkin, J., Canfield, S. G., & Meyer, J. S. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00593-x · Cited by 3
Wellens, S., Gosselet, F., & Culot, M. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105424 · Cited by 3
Induced Pluripotent Stem Cells: Advances and Applications in Regenerative Medicine
Kizub, I. V., Rozhok, A. I., & Bilousova, G. (2023) · Biochemistry · doi:10.5772/intechopen.109274 · Cited by 3
Impaired retinoic acid signaling in cerebral cavernous malformations
Grdseloff, N., Boulday, G., Rödel, C. J., Otten, C., Vannier, D., Cardoso, C., Faurobert, E., Dogra, D., Tournier‐Lasserve, E., & Abdelilah‐Seyfried, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-31905-0 · Cited by 3
Lee, N. G., Lim, M.-H., Park, J., Jeung, I. C., Hwang, B., Lee, J., Park, J., Son, M.-Y., Han, B. S., Yoon, S., et al. (2023) · Bioengineering · doi:10.3390/bioengineering10101132 · Cited by 3
Microbubbles-based drug delivery for antiAlzheimer's drugs
Patel, M. B., Prajapati, B. G., & Yadav, M. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00006-6 · Cited by 3
Eigenmann, D. E. (2015) · edoc (University of Basel) · doi:10.5451/unibas-006499413 · Cited by 3
On the use of the transferrin receptor as a target for brain drug delivery
Johnsen, K. B. (2017) · VBN Forskningsportal (Aalborg Universitet) · doi:10.5278/vbn.phd.med.00108 · Cited by 3
“Primary in vitro models of the BBB have until now been produced from mouse (35), rat (46-49), bovine (2, 50), porcine (51), and human BCECs (52, 53), and their utility as models of the true BBB have to some extent been proven in numerous studies.”
BackgroundBlood-brain barrier model on a microfluidic chip for the study of tumor cell extravasation
Hajal, C. (2018) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 3
Kordbacheh, R., Ashley, M., Cutts, W. D., Keyzer, T. E., Chatterjee, S., Altman, T. J., Alexander, N. G., Sparer, T. E., Kim, B. J., & Sin, J. (2024) · Viruses · doi:10.3390/v16121821 · Cited by 2
“Transendothelial electrical resistance (TEER) was carried out as previously described [23–25].”
Metadata
- Authors
- Lippmann, E. S., Al-Ahmad, A., Azarin, S. M., Palecek, S. P., & Shusta, E. V.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Palecek, Sean P.
- Shusta, Eric V.
- Venue
- Scientific Reports
- Published
- 2014-02-24
- Volume
- 4
- Issue
- 1
- Pages
- 4160-4160
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3932448
- OpenAlex
- W2042883482
- Cited by
- 508
- References
- 51
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 45 · 2023: 55 · 2022: 56 · 2021: 45 · 2020: 58 · 2019: 54 · 2018: 41 · 2017: 34 · 2016: 26 · 2015: 22 · 2014: 10
- FWCI
- 15.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (NS083688)
- Cedars-Sinai Medical Center
- Beijing Municipal Education Commission
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (AA020476, RC4AA020476)
- National Cancer Institute (P30CA014520)
- National Institute of General Medical Sciences (T32GM008505)
- National Institute of Neurological Disorders and Stroke (R01NS083688, NS083688)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- blood-brain barrier model, retinoic acid, human pluripotent stem cells, brain microvascular endothelial cells, pericytes, astrocytes, neural progenitor cells, tight junctions, adherens junctions, multidrug resistance protein, transendothelial electrical resistance, co-culture
- MeSH terms
- Astrocytes, Blood-Brain Barrier, Brain, Cell Differentiation, Cells, Cultured, Electric Conductivity, Endothelium, Vascular, Humans, Models, Biological, Neurons, Tretinoin, Coculture Techniques, Pericytes, Pluripotent Stem Cells, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.